Platinum-based drugs (cisplatin, carboplatin, and oxaliplatin) are widely used therapeutic agents for cancer treatment. Even though the platinum (Pt)-drugs are routinely used clinically, a clear picture of their distribution within tumor tissues is lacking. The current methods to image the ...
Platinum-based drugs (cisplatin, carboplatin, and oxaliplatin) are widely used therapeutic agents for cancer treatment. Even though the platinum (Pt)-drugs are routinely used clinically, a clear picture of their distribution within tumor tissues is lacking. The current methods to image the ...
Platinum-based drugsPolymerdrugsystemReviewTargeted drug delivery systemPlatinum-based (Pt-based) anticancer drugs have been recognised as one of the most effective drugs for clinical treatment of malignant tumors due to its unique mechanism of action and broad range of anticancer spectrum. But, there...
Numerous platinum-based drugs have been synthesized over the years, but only a few of them have been clinically approved. Among these, cisplatin has enjoyed the most success and is used either alone or in combinatorial therapy. Cisplatin was first used for the treatment of cancer in humans in...
Hamelers IH, de Kroon AI. Nanocapsules: a novel formulation technology for platinum-based anticancer drugs. 2007;445-53.Hamelers IH, de Kroon AI. Nanocapsules: a novel formulation technology for platinum-based anticancer drugs. Future Lipidol 2007;2:445–53....
Platinum-based chemotherapy drugs are a type of chemotherapy that uses platinum compounds to treat cancer. These drugs work by damaging the DNA in cancer cells, preventing them from replicating and causing the tumor to shrink. Examples of these drugs include cisplatin, carboplatin, and oxaliplatin....
1. Postoperativechemotherapyschemewascombinationchemotherapythat platinum-based. 术后以铂类为主的联合化疗方案。 paper.pet2008.cn 2. Platinum-baseddrugsareusedextensivelyfortreatingcancer,buttheirusecanbelimitedbytoxicitiesandresistance. 铂类药物被广泛用于治疗癌症,但是他们因为毒性和耐药性使用受到限制。
Nanocapsules: a novel lipid formulation platform for platinum-based anti-cancer drugs [ J ]. J Liposome Res, 2007, 17(3 -4) : 183 -189.Nanocapsules:a no-vel lipid formulation platform for platinum-based anti-cancer drugs. HAMELERS I H,DE KROON A I. Journal of Liposome Research . 2007...
More than four decades after their first approval, platinum drugs still stand among the most widely utilized anti-cancer agents1. Nowadays, almost 50% of cancer patients receiving chemotherapy (CT) are indeed treated with systemic platinum-based regimen1,2. Notwithstanding platinum drugs’ effectivenes...
MAPKi-resistant melanoma cells are susceptible to platinum-based drugs We analysed the chemosensitivity of melanoma cells with acquired resistance to BRAF inhibitor (vemurafenib) (R) or combined BRAF and MEK inhibitor (vemurafenib and trametinib) (DR) treatment and of their sensitive (S) counterparts...